Official Sections CTRMS ISVCA IPITA IPTA ISODP IRTA IXA SPLIT TID

Joint TTS-IPTA Webinar Series on Pediatric Transplantation

TTS Education Committee and the International Society of Pediatric Transplantation (IPTA) have joined together to host a webinar series.

Webinar Feedback Form
Invalid Input

Invalid Input

Invalid Input


WEDNESDAY, APRIL 1, 2020
SOCIAL MEDIA USE IN PEDIATRIC TRANSPLANTATION

TITLE: Social Media Use In Pediatric Transplantation

Moderator: Manuel Rodriguez-Davalos, MD, FACS
Medical Director, Living Donor Liver Transplantation Program
Intermountain Medical Center
Surgical Director, Pediatric Liver Transplantation
Primary Children's Hospital - Intermountain Healthcare
Salt Lake City, UT, USA
Discussant: Sheri Madigan, PhD, R.Psych
Canada Research Chair in Determinants of Child Development
Associate Professor, Department of Psychology
Owerko Centre at the Alberta Children's Hospital Research Institute
University of Calgary
Calgary, AB, Canada
Discussant: Macey Henderson, JD, PhD
Assistant Professor of Surgery, Johns Hopkins University School of Medicine
Director of Policy and External Affairs
The Epidemiology Research Group in Organ Transplantation
Baltimore, MD, USA

TTS Education Committee and the International Society of Pediatric Transplantation (IPTA) Allied Health Professional Committee (AHPC) have joined together to host a webinar. The Allied Health Professional Committee (AHPC) aligns its mission with that of IPTA to advance the science and practice of pediatric transplantation and to improve the health of all children who require transplantation through the various subspecialties of this group, including nursing, nutrition, psycho-social health, developmental, physical and occupational therapies and pharmaceutical management. Under the auspices of IPTA, the AHPC is dedicated to promoting advances in these inter-professional specialties to improve outcomes for all children who receive transplants and their families and to advocate for their rights as transplant candidates and recipients.

Objectives:

  1. Dr. Madigan will review the screen use guidelines. It will also provide attendees the opportunity to consider the potential benefits and consequences of digital media in the lives of children;
  2. Dr. Henderson will introduce the transplant issues, incorporating applications in transplantation and donation as well.

Sheri Madigan's Biography:

Dr. Madigan is an Associate Professor and Canada Research Chair in Determinants of Child Development at the University of Calgary and the Alberta Children’s Hospital Research Institute. Dr. Madigan's research is primarily focused on understanding how early experiences, including exposure to digital technology, can help and/or hinder children’s early learning environments. She has published over 100 peer-reviewed articles describing innovative methods and approaches to understanding determinants of child development. She is the recent recipient of the World Association for Infant Mental Health Early Career Award, as well as the Killam Emerging Research Leader award. Her work has been widely covered in the media, including The New York Times, TIME, The Guardian, and The Globe and Mail. Dr. Madigan is also the child development expert for CTV Morning Live Calgary, providing monthly segments on topics related to parenting and child development

Macey Henderson's Biography:

Dr. Macey Henderson is an Assistant Professor of Surgery at Johns Hopkins. She is an extramurally funded researcher with a diverse portfolio in health policy and management, advocacy, complex healthcare regulations & systems, mobile health technology, social media, and health communications. She is funded by The National Institutes of Health (NIH/NIDDK), The Department of Defense, The Health Resources and Services Administration, the Johns Hopkins Center for AIDS Research (NIH/NIAID), and from other various grants and awards.

Dr. Henderson leads both qualitative and quantitative research projects, clinical trials, and quality improvement studies. Her experience includes implementing evidence-based solutions, including social and digital analytics tools and data mining.

Currently Dr. Henderson is full time faculty at The Johns Hopkins Medical Institutions with a primary appointment in the School Medicine in the Department of Surgery and a joint appointment in the Johns Hopkins University School of Nursing.

She is a Core Faculty member of the Epidemiology Research Group in Organ Transplantation-the largest and most prolific group of its kind, and is the Director of Policy & External Affairs. She is a member of the Board of Directors for the Organ Procurement and Transplantation Network/United Network in Organ Sharing (2017-2020), and has previously served on the Executive Committee. Most recently she was elected to the OPTN/UNOS Executive Committee. She also serves on the OPTN/UNOS Living Donor Committee, the Membership and Professional Standards Committee, and the Patient Affairs Constituent Council.

Manuel Rodriguez-Davalos' Biography:

Manuel Rodriguez-Davalos, Medical Director, Living Donor Liver Transplantation Program, Intermountain Medical Center and Surgical Director, Pediatric Liver Transplantation, Primary Children's Hospital, Intermountain Healthcare. Dr. Rodriguez-Davalos has previously held positions in transplant at Yale University, Mount Sinai Medical Center and New York Medical College.

He is committed to innovation and collaboration to improve organ donation, transplantation and allocation systems to benefit those in need, especially children. He has particular interest in living donor transplants, organ allocation, and portal hypertension.

His current research involves living donor liver transplantation the use of partial grafts and extended criteria for donation in liver transplantation, and preservation techniques for decreasing ischemia-reperfusion injury.

He has served on numerous liver transplantation advisory boards and was a member at large of the United Network for Organ Sharing (UNOS ) Liver Committee and as well as the pediatric transplantation committee. He is part of the publications committee with IPTA, Education committee of TTS, Associate editor of our journal “Transplantation”, Task force for liver allocation with SPLiT and oversees the International Liver Transplant Society Pediatric Liver Transplant Registry.

He received his medical degree from the Anahuac University. He did a year of research in portal hypertension and hepatobiliary surgery at the National Institutes of Health System in Mexico. He was a surgical intern at the Mayo Clinic in Rochester, MN, and completed his surgical training at the Mayo Clinic Hospital in Scottsdale, AZ. He was a clinical fellow in multi-organ transplant surgery at Mount Sinai Medical Center.


WEDNESDAY, FEBRUARY 12, 2020
DONOR CELL FREE DNA TESTING

Daniel C. Brennan and Stanley C. Jordan
Moderated by Medhat Askar

Donor Cell Free DNA Testing
Wednesday, February 12, 2020 - 1:00 PM EST (Montreal time)

Click here to view the recording (you must be logged into the website)

Objectives:
  1. Explain how donor cell free DNA testing is done and the different methods.
  2. Examine how it is different in different organs and in plasma vs. urine.
Daniel C. Brennan's Biography:

Daniel C. Brennan, MD, FACP, was the Alan A. and Edith L. Wolff Professor of Renal Diseases and the Director of Transplant Nephrology at Washington University School of Medicine in St. Louis, Missouri until July 2017 when he was recruited to be the inaugural Medical Director and Co-Director of the Comprehensive Transplant Center at The Johns Hopkins School of Medicine. Dr. Brennan received his BA from Cornell College in Iowa with Distinction in Chemistry and his MD from the University of Iowa College of Medicine. He completed his medical internship and residency at the University of Iowa Hospitals and Clinics. He continued his training with clinical and research fellowships at the Brigham and Women’s Hospital/Harvard Medical School.

Dr. Brennan’s research interests are viral infections, induction immunosuppression therapy, pharmacoeconomic and outcome research in transplantation and islet transplantation. He has written more than 200 original publications and has contributed to several textbooks in these areas. He has been on the Editorial Board of Transplantation since 1998, and a Deputy Editor of Transplantation since 2014, an Associate Editor for the American Journal of Transplantation from 2007-2014, the Editor of the Transplant Section of UpToDate since 1999, and Editor in Chief of Nephrology for UpToDate since 2006. He has served on the editorial board of the American Journal of Kidney Disease, Clinical Journal of the American Society of Nephrology, and Kidney International. He has been a frequent reviewer for many journals including the New England Journal of Medicine and JAMA. He has served on numerous study sections for the NIDDK and the FDA.

He is the recipient of many awards, including the AHA Established Investigator Award 1998; AST Young Investigator Clinical Science Award, 1999; the AST Clinical Science Award, 2003; and the National Kidney Foundation Award of Excellence, 2003 and 2017. He was inducted into the American Society for Clinical Investigation (ASCI), in 2004. He received the Renal Fellows Teaching Award in 2004, 2005, 2009 and 20010. He received the Cornell College Distinguished Alumni Leadership and Service Award in 2011 and the Barnes-Jewish Hospital/Washington University School of Medicine Neville Grant Award for Clinical Excellence in 2011. He received the Friend of Pharmacy award from Barnes-Jewish Hospital in 2012. He received the AST Senior Clinical Transplantation Award in 2016.

Stanley C. Jordan's Biography:

After receiving his undergraduate and medical degrees from the University of North Carolina, Chapel Hill, Dr. Jordan completed a pediatric internship and residency at the University of California, Los Angeles. He completed three fellowships: one in pediatric nephrology at UCLA, one in experimental pathology in the Department of Immunology at Scripps Clinic and Research Foundation, and the third in dialysis and transplantation at Children's Hospital of Los Angeles. He is board certified in pediatrics, pediatric nephrology and diagnostic laboratory immunology.

For more than three decades, Dr. Jordan has focused his research on the immunology of antibody rejection and development of novel immune modulatory therapies to combat this condition. His work is funded by the NIH and grants from biotechnology firms aimed at developing novel therapies in transplant medicine. He has published more than 360 peer reviewed manuscripts and has 10 patent applications pending.

Dr. Jordan has extensive experience with desensitization for incompatible kidney transplantation and currently has 14 investigator-initiated clinical trials examining novel therapies for desensitization and treatment of antibody-mediated rejection. He has also published novel clinical trials using complement inhibitors to prevent delayed graft function in renal allografts. Dr. Jordan and his work have been recognized by his peers and include his being the recipient of the National Kidney Foundation “Gift of Life Award” and the Distinguished Alumni Award from the University of North Carolina Chapel Hill. Recently, he was honored with the inaugural Cedars-Sinai Prize for Research in Scientific Medicine (PRISM), conceived to recognize outstanding scientific and medical breakthroughs, the Pioneer in Medicine Award (also from Cedars-Sinai), the Award for Outstanding Achievement in Transplantation (Clinical ) from the Transplantation Society, the Jean Hamburger Award for outstanding research in nephrology from the International Society of Nephrology and the Senior Achievement Award in Clinical Transplantation from the American Society of Transplantation.

Medhat Askar's Biography:

Medhat Askar, MD, PhD, MSHPE, FRCPath, D(ABHI), D(ABMLI), HCLD(ABB) is a Clinical Professor (Affiliated) in the Department of Pathology and Laboratory Medicine (affiliated) at Texas A&M Health Science Center College of Medicine and the director of the Transplant Immunology and facility director of the Cell Processing Laboratories at Baylor University Medical Center in Dallas, TX, USA. He is the President of The American Society for Histocompatibility and Immunogenetics (ASHI), the Immediate Past President of The American Board of Histocompatibility and Immunogenetics (ABHI). Dr. Askar is a Councilor (North America) and Co-Chair of the TTS Education Committee of The Transplantation Society (TTS). He is also a Member of Board of Directors of United Network for Organ Sharing (UNOS), Organ Procurement and Transplantation Network (OPTN) and a Member of The Joint Commission Pathology Technical Advisory Panel (JC-TAP).


FRIDAY, NOVEMBER 22, 2019
EPITOPE MATCHING

Medhat Askar
Moderated by Katherine Twombley

Epitope Matching
Friday, November 22, 2019 - 1:00 PM EST (Montreal time)

Click here to view the recording (you must be logged into the website)

Objectives:

There are many new advances in the HLA world, and these technologies are developing at a rate faster than we know how to use them clinically. This session will examine the current evidence for and against epitope matching as well as review what is needed for future studies.

Katherine Twombley's Biography:

Katherine Twombley, MD, FAST, FAAP is a Professor in the Department of Pediatrics as well as the College of Graduate of Studies at the Medial University of South Carolina in Charleston, SC where she is also the Chief of Pediatric Nephrology and Medical Director of the Pediatric Kidney Transplant Program. She is on the Council for the International Pediatric Transplant Association (IPTA) and is Chair of the Education committee for IPTA. She is also the Co-Chair of the Executive Committee for the American Society of Transplantation’s Pediatric Community of Practice.

Medhat Askar's Biography:

Medhat Askar, MD, PhD, MSHPE, FRCPath, D(ABHI), D(ABMLI), HCLD(ABB) is a Clinical Professor (Affiliated) in the Department of Pathology and Laboratory Medicine (affiliated) at Texas A&M Health Science Center College of Medicine and the director of the Transplant Immunology and facility director of the Cell Processing Laboratories at Baylor University Medical Center in Dallas, TX, USA. He is the President of The American Society for Histocompatibility and Immunogenetics (ASHI), the Immediate Past President of The American Board of Histocompatibility and Immunogenetics (ABHI). Dr. Askar is a Councilor (North America) and Co-Chair of the TTS Education Committee of The Transplantation Society (TTS). He is also a Member of Board of Directors of United Network for Organ Sharing (UNOS), Organ Procurement and Transplantation Network (OPTN) and a Member of The Joint Commission Pathology Technical Advisory Panel (JC-TAP).

Organizers:

Medhat Askar, MD, PhD, MSHPE, FRCPath, D(ABHI), D(ABMLI), HCLD(ABB)

Director, Transplant Immunology
Assistant Director, Cell Processing Lab
Baylor University Medical Center
Professor, Department of Pathology and Laboratory Medicine,
Texas A&M Health Science Center College of Medicine
President, The American Board of Histocompatibility and Immunogenetics (ABHI)
President-Elect, The American Society for Histocompatibility and Immunogenetics (ASHI)
Member of Board of Directors, United Network for Organ Sharing (UNOS)
Councilor (North America), The Transplantation Society (TTS)
Co-Chair, TTS Education Committee

Katherine Twombley, MD FAAP FAST

Medical Director, Pediatric Kidney Transplant Program
Medical University of South Carolina College of Medicine
Charleston, SC, USA

Social

Contact

Staff Directory
+1-514-874-1717 ,X : 210
This email address is being protected from spambots. You need JavaScript enabled to view it.

Address

International Pediatric Transplant Association
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada